Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Alzheimer’s
Phil’s Journal: A Lesson on Living With Alzheimer’s, Courtesy of My Dog
Underrepresented Communities Face Higher Alzheimer’s Risk — Plus Discrimination At the Doctor’s Office
Family of Wildlife Celebrity Jack Hanna Shares Alzheimer’s Diagnosis
13 New Gene Variants Linked to Alzheimer’s in Pioneering Genome Study
‘The Problem of Alzheimer’s’ Makes Us Mad—In a Good Way
As Our Oceans Change, Drugmakers Dive Deep for an Alzheimer’s Cure
How Young and Old Can Help Each Other Heal & Other March Reads
CBD for Alzheimer’s? The Cannabidiol Craze Makes Its Way Into Research
Study: Recovering From Loneliness Even Better for the Brain Than Never Being Lonely
Managing Language Impairment in Dementia: A LiveTalk With Vicky Fukuhara
Is Alzheimer’s Actually Three Separate Diseases?
Does Eli Lilly’s Alzheimer’s Drug Donanemab Work? Key New Data Released
Expert Q&A: Financial and Insurance Planning After a Dementia Diagnosis
Researchers Explore a New Therapy to Address the Neurological Symptoms of COVID
Now Recruiting: U.S. Trials for Alzheimer’s “Seaweed Drug” Oligomannate
Previous
23
24
25
Next
Page load link
Go to Top